|
|
| | Raltegravir EP impurity H Basic information |
| Product Name: | Raltegravir EP impurity H | | Synonyms: | Raltegravir EP impurity H;Raltegravir Dimer;Ethanediamide, N1,N2-bis[1-[4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]-;Raltegravir Impurity 8（Raltegravir EP Impurity H）;N1,N2-Bis(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)oxalamide (Raltegravir Impurity);Latelavir EP Impurity H;Raltegravir potassium EP Impurity H | | CAS: | 1391918-18-5 | | MF: | C34H36F2N8O8 | | MW: | 722.7 | | EINECS: | | | Product Categories: | | | Mol File: | 1391918-18-5.mol |  |
| | Raltegravir EP impurity H Chemical Properties |
| density | 1.43±0.1 g/cm3(Predicted) | | solubility | DMF (Slightly), DMSO (Slightly) | | pka | 4.20±1.00(Predicted) | | form | Solid | | color | Pale Red |
| | Raltegravir EP impurity H Usage And Synthesis |
| Uses | N1,N2-bis[1-[4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]ethanediamide, is an impurity of Raltegravir Potassium (R100300), a potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug. |
| | Raltegravir EP impurity H Preparation Products And Raw materials |
|